Figure 6.
cbl-b−/− effector CD8+ T cells are resistant to CD4+CD25+ T reg cell suppression. (A) Numbers of tumor infiltration for CD4+CD25+, FoxP3+, and CD8+ cells per 106 tumor cells in cbl-b−/− (n = 4 tumors) and cbl-b+/+ (n = 6 tumors) mice. Data are shown as the mean ± the SEM. Proliferation of wild-type CD8+ effector T cells (B) and proliferation of cbl-b−/− CD8+ effector T cells in the presence of cbl-b+/+ and cbl-b−/− CD4+CD25+ T reg cells at various T reg cell/Teff concentrations (C). Proliferation in B and C was measured by [3H]thymidine incorporation for the last 12 h of a 72-h stimulation with anti-CD3ɛ. Data (mean values of a triplicate culture ± the SEM) are from one out of three different experiments with similar results. (D) Percent suppression of proliferation of CD8+ effector T cells from cbl-b−/− and cbl-b+/+ mice by cbl-b+/+ (WT) and cbl-b−/− (KO) T reg cells at various T reg cell/Teff concentrations.
